Reckitt Report Forecasts Severe Respiratory Virus SeasonNovember 4, 2022
Analysis recently released by Reckitt Professional‘s Lysol Pro Solutions, in partnership with BlueDot Inc. (an artificial and human intelligence organization for detecting, assessing, and responding to global infectious diseases), predicts a potentially severe season of respiratory viruses this winter in the United States.
Research designed for Reckitt by BlueDot suggests the nation could expect a higher incidence from influenza (flu), as those cases return to pre-pandemic levels, while still dealing with COVID-19 cases. The study’s findings concluded that the combination of flu and COVID-19, along with new surges in other respiratory viruses, such as respiratory syncytial virus (RSV), could place an exceptionally high strain on the U.S. medical system.
The study also foresees unpredictability. The country is likely to experience unusually timed peaks in hospitalizations from the flu and COVID-19. The inability to firmly determine the timing of the flu season could make planning for vaccination campaigns much more challenging. The uncertainty will also call for more diligence and caution, as it will be more difficult to determine the flu season’s peak.
In a recent episode of BioTalk, a GBACtv production, Jeff Cross, the media director for ISSA, along with co-host Patricia Olinger, the executive director of the Global Biorisk Advisory Council™ (GBAC), a Division of ISSA,, spoke with John Cordier, CEO and co-founder of Epistemix, and Dr. Donald Burke, president and co-founder of Epistemix, as well as an infectious disease physician and epidemiologist, to learn more about the potential “tripledemic.”
To find out more, watch the video below. Also check out RSV Cleaning and Prevention, Prepare Your Facility for Influenza, and How Commercial Cleaning Practices Have Changed Since COVID-19.
Reckitt Professional is a Parsippany, New Jersey-based manufacturer of branded cleaning and infection control products. For more information, visit www.reckitt.com.